Editor-in-Chief - Orthogate

Editor-in-Chief

Editor-in-Chief 's Latest Stories

Details: Category: Arthritis; Apr 11, 2012

Condition : Rheumatoid Arthritis Intervention : Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Recruiting - verified September 2013

Details: Category: Arthritis; Apr 11, 2012

Condition : Rheumatoid Arthritis Intervention : Sponsor : Hoffmann-La Roche Active, not recruiting - verified February 2014

Details: Category: Arthritis; Apr 11, 2012

Conditions : Rheumatoid Arthritis; Crohn's Disease Intervention : Sponsor : UCB, Inc. Recruiting - verified November 2013

Details: Category: Arthritis; Apr 11, 2012

Condition : Rheumatoid Arthritis Intervention : Sponsor : Hoffmann-La Roche Recruiting - verified November 2013

Details: Category: Arthritis; Apr 10, 2012

Condition : Juvenile Idiopathic Arthritis Intervention : Drug: RoActemra/Actemra (tocilizumab) Sponsor : Hoffmann-La Roche Recruiting - verified February 2014

Details: Category: Arthritis; Apr 10, 2012

Condition : Juvenile Idiopathic Arthritis Intervention : Drug: RoActemra/Actemra (tocilizumab) Sponsor : Hoffmann-La Roche Recruiting - verified November 2013

Details: Category: Arthritis; Apr 10, 2012

Condition : Juvenile Idiopathic Arthritis Intervention : Drug: RoActemra/Actemra (tocilizumab) Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Active, not recruiting - verified September 2013

Details: Category: Arthritis; Mar 26, 2012

Condition : Rheumatoid Arthritis Intervention : Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Recruiting - verified September 2013

Details: Category: Arthritis; Mar 26, 2012

Condition : Rheumatoid Arthritis Intervention : Sponsor : Hoffmann-La Roche Active, not recruiting - verified February 2014

Details: Category: Arthritis; Mar 26, 2012

Condition : Rheumatoid Arthritis Intervention : Sponsor : Hoffmann-La Roche Recruiting - verified November 2013

Page 58 of 684

The independent gateway for the orthopaedic community. Connecting professionals and patients since 1999.

Author listing

Editor-in-Chief 's Latest Stories

An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy

An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy

Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD)

An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy

An Extension Study to WA19977 in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

An Extension Study to WA19977 in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

An Extension Study to WA19977 in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)

An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)

An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)

OG Professionals

Updates

Exchange Forum

Author listing

Editor-in-Chief 's Latest Stories

TPL_FOLLOW_US

OG Professionals

Updates

Exchange Forum